Hemostatic drug. An inhibitor of fibrinolysis. Specifically inhibits the activation of plasminogen and its conversion into plasmin. It has local and systemic hemostatic effect of bleeding, associated with increased fibrinolysis (pathology of platelets, menorragii).
«When result matters!»
For doctors